About Japanese Red Cross Okayama Hospital
Clinical Trials at Japanese Red Cross Okayama Hospital
During the past decade, Japanese Red Cross Okayama Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on
average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Japanese Red Cross Okayama Hospital" #1 sponsor was "Chugai Pharmaceutical" with 2 trials, followed by "Eli Lilly and Company" with 2 trials
sponsored, "Cleerly, Inc." with 1 trials sponsored, "Galapagos NV" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Japanese Red Cross Okayama Hospital"
#1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator and "Toho University - Omori Medical Center" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Japanese Red Cross Okayama Hospital
According to Clinical.Site data, the most researched conditions in "Japanese Red Cross Okayama Hospital" are
"Axial Spondyloarthritis" (1 trials), "Coronary Artery Disease" (1 trials), "Extensive Disease Small Cell Lung Cancer" (1 trials), "Heart Failure" (1 trials) and "Idiopathic Pulmonary Fibrosis" (1 trials). Many other conditions were trialed in "Japanese Red Cross Okayama Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Japanese Red Cross Okayama Hospital
Most popular intervention types in "Japanese Red Cross Okayama Hospital" are "Drug" (5 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Anterior Support Screw" (1 trials), "Baricitinib" (1 trials), "Bevacizumab-EU" (1 trials) and "Bevacizumab-Pfizer" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Japanese Red Cross Okayama Hospital
The vast majority of trials in "Japanese Red Cross Okayama Hospital" are
9 trials for "All" genders.
Clinical Trials Status at Japanese Red Cross Okayama Hospital
Currently, there are NaN active trials in "Japanese Red Cross Okayama Hospital".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Japanese Red Cross Okayama Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Japanese Red Cross Okayama Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".